SCHEMBL4642257

SCHEMBL4642257

CCc1ccc(S(=O)(=O)Cl)c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.36
ALDH1A1 P00352 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
HSD17B10 Q99714 1/20 0.35
CTSB P07858 1/20 0.35
POLB P06746 1/20 0.35
TRPV4 Q9HBA0 2/20 0.34
HTT P42858 2/20 0.34
MCOLN3 Q8TDD5 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
CNR2 P34972 2/20 0.33
PSIP1 O75475 1/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1595970 0.85 LDHA (0.36) LDHAALDH1A1TDP1HSD17B10POLB
SCHEMBL9165551 0.83 ALDH1A1 (0.48) LDHAALDH1A1TDP1HSD17B10POLB
SCHEMBL7791002 0.81 TTR (0.47) LDHAALDH1A1HSD17B10CYP1A2HIF1A
SCHEMBL314045 0.80 LDHA (0.33) LDHAALDH1A1TDP1HSD17B10
SCHEMBL7020846 0.79 THRB (0.42) LDHAALDH1A1HSD17B10CTSBHTT
SCHEMBL7020849 0.79 TTR (0.46) LDHAALDH1A1HSD17B10CYP1A2HIF1A
SCHEMBL30537735 0.78 GABRA1 (0.43) ALDH1A1HTTCNR2CYP1A2
SCHEMBL5682891 0.78 GABRA1 (0.43) ALDH1A1HTTCNR2CYP1A2
SCHEMBL29352142 0.77 CNR2 (0.39) ALDH1A1LMNACNR2L3MBTL1
SCHEMBL22116822 0.76 COMT (0.50) ALDH1A1TDP1HSD17B10POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678196-B1 SULFONYLAMINO-PEPTIDOMIMETICS ACTIVE ON THE SOMATOSTATIN RECEPTOR SUBTYPES 4 (SSTR4) AND 1 (SSTR1) WURSTER SIEGFRIED (FI) 2008-08-13 EP disclosed
US-20070129313-A1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) SIEGFRIED WURSTER (FI) 2007-06-07 US disclosed
EP-1678196-A1 SULFONYLAMINO-PEPTIDOMIMETICS ACTIVE ON THE SOMATOSTATIN RECEPTOR SUBTYPES 4 (SSTR4) AND 1 (SSTR1) Oy Juvantia Pharma Ltd (FI) 2006-07-12 EP disclosed
WO-2005033124-A1 SULFONYLAMINO-PEPTIDOMIMETICS ACTIVE ON THE SOMATOSTATIN RECEPTOR SUBTYPES 4 (SSTR4) AND 1 (SSTR1) OY JUVANTIA PHARMA LTD (FI) 2005-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129313-A1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) SSTR4, SSTR1, SSTR3 LDHA 4656/4885ALDH1A1 2722/4885TDP1 4316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.